FSMAX
Price
$88.17
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
PEMGX
Price
$43.77
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

FSMAX vs PEMGX

Header iconFSMAX vs PEMGX Comparison
Open Charts FSMAX vs PEMGXBanner chart's image
Fidelity Extended Market Index
Price$88.17
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Principal MidCap A
Price$43.77
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSMAX vs PEMGX Comparison Chart
Loading...
VS
FSMAX vs. PEMGX commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongSell and PEMGX is a Sell.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. PEMGX (28.1B). FSMAX pays higher dividends than PEMGX: FSMAX (1.10) vs PEMGX (0.00). FSMAX was incepted earlier than PEMGX: FSMAX (13 years) vs PEMGX (19 years). FSMAX is a more actively managed with annual turnover of: 18.00 vs. PEMGX (10.10). FSMAX has a lower initial minimum investment than PEMGX: FSMAX (0) vs PEMGX (1000). FSMAX annual gain was more profitable for investors over the last year : 31.46 vs. PEMGX (29.85). FSMAX (46.11) and PEMGX (45.14) have equivalent 5 years return.
FSMAXPEMGXFSMAX / PEMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years19 years-
Gain YTD12.95218.57370%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets40B28.1B142%
Annual Yield % from dividends1.100.00-
Returns for 1 year31.4629.85105%
Returns for 3 years-4.61-1.20384%
Returns for 5 years46.1145.14102%
Returns for 10 years73.7697.5676%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIA4.930.34
+7.41%
Citizens
DAVA23.970.26
+1.10%
Endava plc
UFCS19.42-0.07
-0.36%
United Fire Group
AU27.14-0.15
-0.55%
AngloGold Ashanti plc
PTPI0.34N/A
-0.89%
Petros Pharmaceuticals